Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism

The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I...

Full description

Saved in:
Bibliographic Details
Published inActa biochimica et biophysica Sinica Vol. 46; no. 7; pp. 597 - 604
Main Authors Gao, Minjie, Gao, Lu, Yang, Guang, Tao, Yi, Hou, Jun, Xu, Hongwei, Hu, Xiaojing, Han, Ying, Zhang, Qianqiao, Zhan, Fenghuang, Wu, Xiaosong, Shi, Jumei
Format Journal Article
LanguageEnglish
Published China 01.07.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I and HLA-G in patient myeloma cells, and determined their relevance in patient tumor-cell susceptibility to NK cell cytotoxicity. Our results showed that patient myeloma cells (n = 12) were relatively resistant to NK-92 cell lysis, compared with myeloma cell lines (n = 7, P 〈 0.01). Gene expression profiling and flow cytometry analysis showed that both mRNA and protein of HLA class I were highly expressed in 12 patient mycloma cells. Interestingly, no or low HLA-G surface expression was detected, although multiple HLA-G transcripts were detected in these mycloma cells. NK cell function assay showed that down-regulating HLA class I expression on patient cells by acid treatment significantly increased the susceptibility of MM cells to NK-mediated lysis. Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibodies on myeloma samples markedly increased their susceptibility to NK-mediated killing. These results demonstrated that the resistance of patient MM cells to NK lysis mainly involves an I-ILA class l- dependent mechanism, suggesting that HLA class I may be involved in protecting MM cells from NK-mediated attack and contribute to their immune escape in vivo.
AbstractList The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I and HLA-G in patient myeloma cells, and determined their relevance in patient tumor-cell susceptibility to NK cell cytotoxicity. Our results showed that patient myeloma cells (n = 12) were relatively resistant to NK-92 cell lysis, compared with myeloma cell lines (n = 7, P < 0.01). Gene expression profiling and flow cytometry analysis showed that both mRNA and protein of HLA class I were highly expressed in 12 patient myeloma cells. Interestingly, no or low HLA-G surface expression was detected, although multiple HLA-G transcripts were detected in these myeloma cells. NK cell function assay showed that down-regulating HLA class I expression on patient cells by acid treatment significantly increased the susceptibility of MM cells to NK-mediated lysis. Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibodies on myeloma samples markedly increased their susceptibility to NK-mediated killing. These results demonstrated that the resistance of patient MM cells to NK lysis mainly involves an HLA class I-dependent mechanism, suggesting that HLA class I may be involved in protecting MM cells from NK-mediated attack and contribute to their immune escape in vivo.
The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I and HLA-G in patient myeloma cells, and determined their relevance in patient tumor-cell susceptibility to NK cell cytotoxicity. Our results showed that patient myeloma cells (n = 12) were relatively resistant to NK-92 cell lysis, compared with myeloma cell lines (n = 7, P < 0.01). Gene expression profiling and flow cytometry analysis showed that both mRNA and protein of HLA class I were highly expressed in 12 patient myeloma cells. Interestingly, no or low HLA-G surface expression was detected, although multiple HLA-G transcripts were detected in these myeloma cells. NK cell function assay showed that down-regulating HLA class I expression on patient cells by acid treatment significantly increased the susceptibility of MM cells to NK-mediated lysis. Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibodies on myeloma samples markedly increased their susceptibility to NK-mediated killing. These results demonstrated that the resistance of patient MM cells to NK lysis mainly involves an HLA class I-dependent mechanism, suggesting that HLA class I may be involved in protecting MM cells from NK-mediated attack and contribute to their immune escape in vivo.
The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I and HLA-G in patient myeloma cells, and determined their relevance in patient tumor-cell susceptibility to NK cell cytotoxicity. Our results showed that patient myeloma cells (n = 12) were relatively resistant to NK-92 cell lysis, compared with myeloma cell lines (n = 7, P 〈 0.01). Gene expression profiling and flow cytometry analysis showed that both mRNA and protein of HLA class I were highly expressed in 12 patient mycloma cells. Interestingly, no or low HLA-G surface expression was detected, although multiple HLA-G transcripts were detected in these mycloma cells. NK cell function assay showed that down-regulating HLA class I expression on patient cells by acid treatment significantly increased the susceptibility of MM cells to NK-mediated lysis. Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibodies on myeloma samples markedly increased their susceptibility to NK-mediated killing. These results demonstrated that the resistance of patient MM cells to NK lysis mainly involves an I-ILA class l- dependent mechanism, suggesting that HLA class I may be involved in protecting MM cells from NK-mediated attack and contribute to their immune escape in vivo.
Author Minjie Gao Lu Gao Guang Yang Yi Tao Jun Hou Hongwei Xu Xiaojing Hu Ying Han Qianqiao Zhang Xiaosong Wu Jumei Shi
AuthorAffiliation Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA 52242, USA
Author_xml – sequence: 1
  givenname: Minjie
  surname: Gao
  fullname: Gao, Minjie
  organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
– sequence: 2
  givenname: Lu
  surname: Gao
  fullname: Gao, Lu
  organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
– sequence: 3
  givenname: Guang
  surname: Yang
  fullname: Yang, Guang
  organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
– sequence: 4
  givenname: Yi
  surname: Tao
  fullname: Tao, Yi
  organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
– sequence: 5
  givenname: Jun
  surname: Hou
  fullname: Hou, Jun
  organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
– sequence: 6
  givenname: Hongwei
  surname: Xu
  fullname: Xu, Hongwei
  organization: Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA 52242, USA
– sequence: 7
  givenname: Xiaojing
  surname: Hu
  fullname: Hu, Xiaojing
  organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
– sequence: 8
  givenname: Ying
  surname: Han
  fullname: Han, Ying
  organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
– sequence: 9
  givenname: Qianqiao
  surname: Zhang
  fullname: Zhang, Qianqiao
  organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
– sequence: 10
  givenname: Fenghuang
  surname: Zhan
  fullname: Zhan, Fenghuang
  organization: Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA 52242, USA
– sequence: 11
  givenname: Xiaosong
  surname: Wu
  fullname: Wu, Xiaosong
  email: shijumei@hotmail.com, wuxiaosong@gmail.com
  organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China shijumei@hotmail.com wuxiaosong@gmail.com
– sequence: 12
  givenname: Jumei
  surname: Shi
  fullname: Shi, Jumei
  email: shijumei@hotmail.com, wuxiaosong@gmail.com
  organization: Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China shijumei@hotmail.com wuxiaosong@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24850305$$D View this record in MEDLINE/PubMed
BookMark eNo9kM9Lw0AQhRepWFs9eZfFkyCxO7v51WMpaotVL3oTwuxm0kaSTZtNCv3vTW3taYbHx-PxDVjPVpYYuwHxCGKsRqi1Gy3LVvhwxi4h8gMvkpHodX8YSW8MftBnA-d-hFBhCOKC9aUfB0KJ4JJ9v-2oqErkhorC8Zpc7hq0hnhT8ffXv5gXuy7lJea22PHcbqtiS46j5bPFhJsCneNzL6U12ZRsw0syK7S5K6_YeYaFo-vjHbKv56fP6cxbfLzMp5OFZxSEjadII3TDEMcakASS1KCkL8dSZymgMTqQfpD5EBkESCnOwjiTYOI40hjHasjuD73rutq05JqkzN1-OVqqWpdA4IOKpZJRhz4cUFNXztWUJes6L7HeJSCSvc5krzM56Ozo22Nxq0tKT-y_vw64O9atKrvc5HZ5YsJQduZBSvULyjR_KA
CitedBy_id crossref_primary_10_3389_fimmu_2020_575609
crossref_primary_10_3389_fimmu_2021_816499
crossref_primary_10_1002_acg2_49
crossref_primary_10_1002_jcp_30575
crossref_primary_10_3390_ijms20143472
crossref_primary_10_1111_bjh_14570
crossref_primary_10_3389_fonc_2022_834072
crossref_primary_10_3389_fimmu_2018_01415
crossref_primary_10_1051_bioconf_20225501010
crossref_primary_10_3389_fimmu_2018_02848
crossref_primary_10_3389_fonc_2020_01290
crossref_primary_10_3390_cancers12040817
crossref_primary_10_1016_j_ctrv_2018_10_005
crossref_primary_10_1016_j_mam_2021_100968
crossref_primary_10_3389_fonc_2021_731957
crossref_primary_10_3390_ijms23052847
crossref_primary_10_1016_j_ejps_2023_106492
crossref_primary_10_1016_j_jtbi_2018_08_037
Cites_doi 10.1182/blood-2005-09-3671
10.1111/j.1399-0039.2011.01716.x
10.1182/blood-2004-04-1422
10.1182/blood-2007-09-077438
10.1111/j.1365-2141.2008.07340.x
10.1002/eji.200737089
10.1146/annurev.immunol.23.021704.115526
10.1038/87766
10.1007/s00262-013-1493-8
10.1182/blood.V95.2.610
10.1084/jem.184.3.913
10.1016/0092-8674(85)90103-5
10.1073/pnas.86.7.2361
10.1159/000203610
10.1146/annurev.genom.7.080505.115726
10.1182/blood-2007-10-116129
10.1007/s00262-013-1469-8
10.1007/s11864-014-0276-6
10.1038/348213a0
10.1182/blood-2007-09-110312
10.1182/blood-2007-03-078535
10.1182/blood-2011-06-360255
10.1073/pnas.83.15.5688
10.1016/S1499-3872(11)60025-8
10.1038/leu.2008.15
10.1586/17474086.2014.882764
10.4049/jimmunol.159.3.1072
10.1007/BF02827242
10.1073/pnas.94.21.11520
10.1016/j.exphem.2013.01.010
10.1089/152581601750288975
10.1016/S0171-2985(00)80050-9
10.4049/jimmunol.175.8.4866
10.4049/jimmunol.138.6.1657
ContentType Journal Article
Copyright The Author 2014. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
Copyright_xml – notice: The Author 2014. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
DBID 2RA
92L
CQIGP
W94
WU4
~WA
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1093/abbs/gmu041
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-自然科学
中文科技期刊数据库-自然科学-生物科学
中文科技期刊数据库- 镜像站点
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism
EISSN 1745-7270
EndPage 604
ExternalDocumentID 10_1093_abbs_gmu041
24850305
662145122
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-01
-0A
-SA
-S~
.2P
.3N
.I3
0R~
188
1OC
1TH
23M
2RA
31~
36B
4.4
48X
53G
5GY
5VR
5VS
5XA
5XB
5XL
6J9
70D
8-1
8RM
92L
92M
9D9
9DA
AABJS
AABMN
AAESY
AAIJN
AAIMJ
AAIYJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPQZ
AAPXW
AAUQX
AAVAP
AAVLN
ABEUO
ABIXL
ABNKS
ABPTD
ABQLI
ABZBJ
ACGFO
ACGFS
ACUFI
ACXQS
ACYTK
ADBBV
ADEIU
ADEYI
ADFTL
ADGZP
ADHKW
ADHZD
ADOCK
ADORX
ADQLU
ADRIX
ADRTK
ADYVW
ADZTZ
ADZXQ
AECKG
AEGPL
AEGXH
AEJOX
AEKKA
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFBPY
AFFZL
AFIYH
AFOFC
AFUIB
AFXEN
AFZJQ
AGINJ
AGKEF
AGSYK
AHXPO
AIJHB
AIKOY
AJAOE
AJEUX
AKHUL
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALTZX
ALUQC
APIBT
APWMN
ARIXL
ARQIP
AUCZF
AXUDD
AYOIW
AZFZN
AZQFJ
AZVOD
BAWUL
BAYMD
BCRHZ
BEYMZ
BFHJK
BHONS
BQDIO
BQUQU
BSWAC
BTQHN
BYORX
CAG
CAJEA
CAJUS
CASEJ
CCEZO
CCVFK
CDBKE
CHBEP
CO8
COF
CQIGP
CS3
CW9
CZ4
DAKXR
DCZOG
DIK
DILTD
DPORF
DPPUQ
D~K
E3Z
EBS
EE~
EJD
EMB
EMOBN
EX3
F5P
F9B
FA0
FHSFR
FLIZI
FLUFQ
FOEOM
FQBLK
GAUVT
GJXCC
GROUPED_DOAJ
GX1
H5~
HAR
HH5
HW0
HZ~
IOX
J21
JUIAU
K97
KOP
KSI
KSN
M-Z
M49
N9A
NGC
NLBLG
NMDNZ
NU-
O9-
OAWHX
ODMLO
OJQWA
OJZSN
OK1
OVD
PAFKI
PEELM
Q--
Q-0
Q1.
Q5Y
R-A
RD5
ROX
RPM
RT1
RUSNO
RW1
RXO
S..
SV3
T8Q
TEORI
TJP
TLC
U1F
U1G
U5A
U5K
UZ3
UZ4
W2D
W94
WOW
WU4
X7H
YAYTL
YKOAZ
YXANX
~91
~WA
AAXDM
ABXVV
CGR
CUY
CVF
ECM
EIF
H13
NPM
AASNB
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c316t-3eba1610aa9b1ae0ae2b1324292bfd1accb5245f417ca11de8f68f21c887ba883
ISSN 1672-9145
IngestDate Fri Oct 25 04:52:28 EDT 2024
Fri Aug 23 02:40:10 EDT 2024
Tue Oct 15 23:50:27 EDT 2024
Wed Feb 14 10:20:49 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords HLA class I
natural killer cells
myeloma
cytotoxicity
Language English
License The Author 2014. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c316t-3eba1610aa9b1ae0ae2b1324292bfd1accb5245f417ca11de8f68f21c887ba883
Notes Minjie Gao, Lu Gao, Guang Yang, Yi Tao, Jun Hou, Hongwei Xu, Xiaojing Hu, Ying Han, Qianqiao Zhang, Fenghuang Zhan, Xiaosong Wu, and Jumei Shi.1.Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China 2Department of Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, IA 52242, USA tThese authors contributed equally to this work. *Correspondence address. Tel: + 86-21-66306764; Fax: + 86-21-66301051; E-mail: shijumei@hotmail.com (J.S.)/Tel: + 86-21-66306764; Fax: +86-21-66301051; E-mail: wuxiaosong@gmail.com (X.W.)
31-1940/Q
The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell cytotoxicity to myeloma cells remains unclear. In the present study, we investigated the expressions of human leukocyte antigen (HLA) class I and HLA-G in patient myeloma cells, and determined their relevance in patient tumor-cell susceptibility to NK cell cytotoxicity. Our results showed that patient myeloma cells (n = 12) were relatively resistant to NK-92 cell lysis, compared with myeloma cell lines (n = 7, P 〈 0.01). Gene expression profiling and flow cytometry analysis showed that both mRNA and protein of HLA class I were highly expressed in 12 patient mycloma cells. Interestingly, no or low HLA-G surface expression was detected, although multiple HLA-G transcripts were detected in these mycloma cells. NK cell function assay showed that down-regulating HLA class I expression on patient cells by acid treatment significantly increased the susceptibility of MM cells to NK-mediated lysis. Furthermore, we found that the blocking of membrane-bound HLA class I rather than HLA-G using antibodies on myeloma samples markedly increased their susceptibility to NK-mediated killing. These results demonstrated that the resistance of patient MM cells to NK lysis mainly involves an I-ILA class l- dependent mechanism, suggesting that HLA class I may be involved in protecting MM cells from NK-mediated attack and contribute to their immune escape in vivo.
myeloma; natural killer cells; cytotoxicity;HLA class I
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24850305
PQID 1541382327
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1541382327
crossref_primary_10_1093_abbs_gmu041
pubmed_primary_24850305
chongqing_primary_662145122
PublicationCentury 2000
PublicationDate 2014-07-01
PublicationDateYYYYMMDD 2014-07-01
PublicationDate_xml – month: 07
  year: 2014
  text: 2014-07-01
  day: 01
PublicationDecade 2010
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Acta biochimica et biophysica Sinica
PublicationTitleAlternate Acta Biochimica et Biophysica Sinica
PublicationYear 2014
References Ames E (null) 2014; 63
Tinhofer I (null) 2000; 95
Sawanobori M (null) 1997; 98
Shi J (null) 2008; 143
Fan QR (null) 2001; 2
Genadieva-Stavric S (null) 2014
Söderström K (null) 1997; 159
Benson DM (null) 2011; 118
Wang Y (null) 2011; 10
Elliott RL (null) 2011; 26
Kumar SK (null) 2008; 111
Maki G (null) 2008; 22
Cao M (null) 2011; 78
Maki G (null) 2001; 10
Bashirova AA (null) 2006; 7
Liu C (null) 2013; 41
Harel-Bellan A (null) 1986; 83
Laubach JP (null) 2014; 7
Storkus WJ (null) 1987; 138
Lanier LL (null) 2005; 23
Collins SM (null) 2013; 62
Van Bleek GM (null) 1990; 348
Apps R (null) 2007; 37
Rebmann V (null) 2007; 17
Rebmann V (null) 2003; 13
Shi J (null) 2008; 111
Caligiuri MA (null) 2008; 112
Mandelboim O (null) 1996; 184
Rouas-Freiss N (null) 1997; 94
Storkus WJ (null) 1989; 86
Alici E (null) 2008; 111
Beyer M (null) 2006; 107
Carbone E (null) 2005; 105
Townsend AR (null) 1985; 42
Allan DS (null) 2000; 202
Gonen-Gross T (null) 2005; 175
Gong JH (null) 1994; 8
Frassanito MA (null) 1997; 27
References_xml – volume: 107
  start-page: 3940
  year: 2006
  ident: null
  publication-title: Blood
  doi: 10.1182/blood-2005-09-3671
  contributor:
    fullname: Beyer M
– volume: 78
  start-page: 120
  year: 2011
  ident: null
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.2011.01716.x
  contributor:
    fullname: Cao M
– volume: 105
  start-page: 251
  year: 2005
  ident: null
  publication-title: Blood
  doi: 10.1182/blood-2004-04-1422
  contributor:
    fullname: Carbone E
– volume: 8
  start-page: 652
  year: 1994
  ident: null
  publication-title: Leukemia
  contributor:
    fullname: Gong JH
– volume: 112
  start-page: 461
  year: 2008
  ident: null
  publication-title: Blood
  doi: 10.1182/blood-2007-09-077438
  contributor:
    fullname: Caligiuri MA
– volume: 143
  start-page: 641
  year: 2008
  ident: null
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2008.07340.x
  contributor:
    fullname: Shi J
– volume: 17
  start-page: 430
  year: 2007
  ident: null
  publication-title: Semin Cell Biol
  contributor:
    fullname: Rebmann V
– volume: 13
  start-page: 371
  year: 2003
  ident: null
  publication-title: Semin Cell Biol
  contributor:
    fullname: Rebmann V
– volume: 37
  start-page: 1924
  year: 2007
  ident: null
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200737089
  contributor:
    fullname: Apps R
– volume: 23
  start-page: 225
  year: 2005
  ident: null
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.23.021704.115526
  contributor:
    fullname: Lanier LL
– volume: 2
  start-page: 452
  year: 2001
  ident: null
  publication-title: Nat Immunol
  doi: 10.1038/87766
  contributor:
    fullname: Fan QR
– volume: 62
  start-page: 1841
  year: 2013
  ident: null
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-013-1493-8
  contributor:
    fullname: Collins SM
– volume: 95
  start-page: 610
  year: 2000
  ident: null
  publication-title: Blood
  doi: 10.1182/blood.V95.2.610
  contributor:
    fullname: Tinhofer I
– volume: 184
  start-page: 913
  year: 1996
  ident: null
  publication-title: J Exp Med
  doi: 10.1084/jem.184.3.913
  contributor:
    fullname: Mandelboim O
– volume: 42
  start-page: 457
  year: 1985
  ident: null
  publication-title: Cell
  doi: 10.1016/0092-8674(85)90103-5
  contributor:
    fullname: Townsend AR
– volume: 86
  start-page: 2361
  year: 1989
  ident: null
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.86.7.2361
  contributor:
    fullname: Storkus WJ
– volume: 98
  start-page: 150
  year: 1997
  ident: null
  publication-title: Acta Haematol
  doi: 10.1159/000203610
  contributor:
    fullname: Sawanobori M
– volume: 7
  start-page: 277
  year: 2006
  ident: null
  publication-title: Annu Rev Genomics Hum Genet
  doi: 10.1146/annurev.genom.7.080505.115726
  contributor:
    fullname: Bashirova AA
– volume: 111
  start-page: 2516
  year: 2008
  ident: null
  publication-title: Blood
  doi: 10.1182/blood-2007-10-116129
  contributor:
    fullname: Kumar SK
– volume: 63
  start-page: 21
  year: 2014
  ident: null
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-013-1469-8
  contributor:
    fullname: Ames E
– year: 2014
  ident: null
  publication-title: Curr Treat Options Oncol
  doi: 10.1007/s11864-014-0276-6
  contributor:
    fullname: Genadieva-Stavric S
– volume: 348
  start-page: 213
  year: 1990
  ident: null
  publication-title: Nature
  doi: 10.1038/348213a0
  contributor:
    fullname: Van Bleek GM
– volume: 111
  start-page: 3155
  year: 2008
  ident: null
  publication-title: Blood
  doi: 10.1182/blood-2007-09-110312
  contributor:
    fullname: Alici E
– volume: 111
  start-page: 1309
  year: 2008
  ident: null
  publication-title: Blood
  doi: 10.1182/blood-2007-03-078535
  contributor:
    fullname: Shi J
– volume: 118
  start-page: 6387
  year: 2011
  ident: null
  publication-title: Blood
  doi: 10.1182/blood-2011-06-360255
  contributor:
    fullname: Benson DM
– volume: 83
  start-page: 5688
  year: 1986
  ident: null
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.83.15.5688
  contributor:
    fullname: Harel-Bellan A
– volume: 26
  start-page: 153
  year: 2011
  ident: null
  publication-title: Cancer Biother Radiopharm
  contributor:
    fullname: Elliott RL
– volume: 10
  start-page: 158
  year: 2011
  ident: null
  publication-title: Hepatobiliary Pancreat Dis Int
  doi: 10.1016/S1499-3872(11)60025-8
  contributor:
    fullname: Wang Y
– volume: 22
  start-page: 998
  year: 2008
  ident: null
  publication-title: Leukemia
  doi: 10.1038/leu.2008.15
  contributor:
    fullname: Maki G
– volume: 7
  start-page: 97
  year: 2014
  ident: null
  publication-title: Expert Rev Hematol
  doi: 10.1586/17474086.2014.882764
  contributor:
    fullname: Laubach JP
– volume: 159
  start-page: 1072
  year: 1997
  ident: null
  publication-title: J Immunol
  doi: 10.4049/jimmunol.159.3.1072
  contributor:
    fullname: Söderström K
– volume: 27
  start-page: 48
  year: 1997
  ident: null
  publication-title: Int J Clin Lab Res
  doi: 10.1007/BF02827242
  contributor:
    fullname: Frassanito MA
– volume: 94
  start-page: 11520
  year: 1997
  ident: null
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.94.21.11520
  contributor:
    fullname: Rouas-Freiss N
– volume: 41
  start-page: 508
  year: 2013
  ident: null
  publication-title: Exp Hematol
  doi: 10.1016/j.exphem.2013.01.010
  contributor:
    fullname: Liu C
– volume: 10
  start-page: 369
  year: 2001
  ident: null
  publication-title: J Hematother Stem Cell Res
  doi: 10.1089/152581601750288975
  contributor:
    fullname: Maki G
– volume: 202
  start-page: 34
  year: 2000
  ident: null
  publication-title: Immunobiology
  doi: 10.1016/S0171-2985(00)80050-9
  contributor:
    fullname: Allan DS
– volume: 175
  start-page: 4866
  year: 2005
  ident: null
  publication-title: J Immunol
  doi: 10.4049/jimmunol.175.8.4866
  contributor:
    fullname: Gonen-Gross T
– volume: 138
  start-page: 1657
  year: 1987
  ident: null
  publication-title: J Immunol
  doi: 10.4049/jimmunol.138.6.1657
  contributor:
    fullname: Storkus WJ
SSID ssj0036610
Score 2.1720614
Snippet The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell...
The anti-multiple myeloma (MM) potential of natural killer (NK) cells has been of rising interest in recent years. However, the molecular mechanism of NK cell...
SourceID proquest
crossref
pubmed
chongqing
SourceType Aggregation Database
Index Database
Publisher
StartPage 597
SubjectTerms Cell Line, Tumor
Cytotoxicity, Immunologic
Down-Regulation
Flow Cytometry
Gene Expression Profiling
HLA Antigens - immunology
HLA-G
Humans
Killer Cells, Natural - immunology
Multiple Myeloma - genetics
Multiple Myeloma - immunology
Multiple Myeloma - pathology
NK细胞活性
人类白细胞抗原
依赖性
分子机制
流式细胞仪分析
细胞裂解
骨髓瘤细胞
Title Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism
URI http://lib.cqvip.com/qk/90160X/201407/662145122.html
https://www.ncbi.nlm.nih.gov/pubmed/24850305
https://search.proquest.com/docview/1541382327
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeqISReEN-UATISfooy8h3nMR2tyrZOQnSiSEiVnThdpjVhNBEa_yv_C3dxkhUYCHiIY9nOKbn7-XK2fHeEvExsZaGHoplEqTTRtdPkXhqZme8phb6XykXn5NlxMD3xDhb-YjD4tnVqqa7kXvL1Wr-S_5EqtIFc0Uv2HyTbE4UGqIN8oQQJQ_lXMp5dqvNyLQzcfcft_w0agzhTwaA8PmyaDR1yZC3y4hxd_EAbYZxZmNXTo9hI0HY23phdKtzKWCt0Be7iCrZWKxuHLPJYNMEKj1gcsbHP-D6LAqzEr1kMFY-NOOPj6wZvVSKL8e2nAsZjFvtsPGEjIBizMRAZsZGNXUCfh-3jvD90O8uLsxzQLUrjqG5uAPRiZXxoityYQ8tBDV9Y1nAVqy8qNxa1schFeYY7I9MaRuEduPAWpscFdBjNznkzZoPpl97XQGIND747zbd3RmyvP0XbKfMgdECZ63CVe0q3hR6m79XJSlpsh1sK3NenhVtbINCpkX_5zegQXEJKmGuT1bq2dPCunyJ3BwGGgbcdsBBuOKAHg24zSRsKLphGjb9u95qt-ygQx0Rym1eaMAb9OIUPvwDG_Gg8_WZF1FhG8zvkdrukobHG510yUMU9clMnOb28Tz62KKUNSukVSmlV0uPDppk2KKUapbRDKRUFBZTSBqV0C6W0R-kDcjIZz_enZpvTw0xcO6hMV0kBiwxLiEjaQllCOdJGoz5yZJbaIkmk73h-5tlhImw7VTwLeObYCfwMpeDcfUh2irJQjwlVSoZeBuNTnsGyIwCeSSvNMtdNwjC10iHZ7Rm3_KRjtyx7mQxBT7Ws7Dv1gQx3idxfau4PyYuOzUtQvMgSUaiy3ixh7YHxO10nHJJHmv89IYwTiH_SJ398hV1y6wq2T8lO9blWz8DEreTzBijfAfLXmUk
link.rule.ids 315,783,787,27936,27937
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Myeloma+cells+resistance+to+NK+cell+lysis+mainly+involves+an+HLA+class+I-dependent+mechanism&rft.jtitle=%E7%94%9F%E7%89%A9%E5%8C%96%E5%AD%A6%E4%B8%8E%E7%94%9F%E7%89%A9%E7%89%A9%E7%90%86%E5%AD%A6%E6%8A%A5%EF%BC%9A%E8%8B%B1%E6%96%87%E7%89%88&rft.au=Minjie+Gao+Lu+Gao+Guang+Yang+Yi+Tao+Jun+Hou+Hongwei+Xu+Xiaojing+Hu+Ying+Han+Qianqiao+Zhang+Xiaosong+Wu+Jumei+Shi&rft.date=2014-07-01&rft.issn=1672-9145&rft.eissn=1745-7270&rft.issue=7&rft.spage=597&rft.epage=604&rft_id=info:doi/10.1093%2Fabbs%2Fgmu041&rft.externalDocID=662145122
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90160X%2F90160X.jpg